Media contacts


 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

Evan O’Connell
+41 22 909 65 28
+41 79 682 18 95
eoconnell@gavi.org

Evan O’Connell

Laura Shevlin
+ 41 79 529 92 87
lshevlin@gavi.org
 

Laura Shevlin

Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org

Cirũ Kariũki

Collins Weru Mwai
+250787836638
cmwai@gavi.org

Collins Weru Mwai

Latest news releases

View all

3 November 2022

Global health agencies outline plan to support Ugandan government-led response to outbreak of Ebola virus disease

3 November 2022 – Following the declaration of an Ebola outbreak in Uganda on 20 September 2022, the outbreak has now spread to seven districts (Kasanda, Kyegegwa, Bunyangabu and Kagadi districts beyond the original epicenter in Mubende district…

3 November 2022

Gavi sets course to support sustainable vaccine manufacturing in Africa with new action plan in support of the African Union’s 2040 vision

Gavi publishes plan of action to support the development of sustainable vaccine manufacturing in Africa.

28 October 2022

Lower-income countries push to reach more than 85 million children with measles vaccine

Following an alarming global rise in measles cases and outbreaks, lower Income countries are accelerating efforts with support from Gavi, the Vaccine Alliance.

17 October 2022

Gavi, Moderna update COVAX supply agreement; agree on access to variant-containing vaccines for lower-income countries

Gavi and Moderna agree to cancel remaining volumes under existing COVAX supply agreement.

3 October 2022

Sierra Leone introduces HPV vaccine to protect girls from cervical cancer

In a move to protect adolescent girls from cervical cancer, the Government of Sierra Leone today introduced the Human Papilloma Virus (HPV) vaccine to the routine immunisation schedule and launched the start of a campaign to reach 153,991 girls…

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi progress reports

Credit: Gavi/2013/Evelyn Hockstein

Types of support

GAVI/2017/Juliette Bastin/Burkina Faso

Country hub

Country hub

Gavi leadership

 

José Manuel Barroso
Board Chair

José Manuel Barroso

Dr Seth Berkley
CEO

Dr Seth Berkley

David Marlow
Gavi COO

David Marlow

Opinions

View all

29 September 2022

APR 2021: Recognising country commitment

Prof José Manuel Barroso, Chair of the Gavi Board, reflects on the achievements of lower-income countries during the pandemic.

29 September 2022

APR 2021: Reflecting on 2021, the global imperative for 2022

Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, looks back on the first year of Gavi 5.0

26 September 2022

Preparing for the Next Global Catastrophe

The end of the pandemic may be in sight, but COVID-19 could be a harbinger of future calamities. If global leaders do not establish equitable mechanisms to respond before the next big crisis strikes, low-income countries and high-risk groups will…

30 May 2022

The last to receive COVID vaccines are the hardest and most critical to reach

There must be a way to help people cover gaps in health care costs without forcing them to be public about their most private concerns.

25 May 2022

The pandemic is far from over: how can the private sector help us fight it?

We are still in the acute phase of the pandemic, with cases continuing to rise in many countries and vaccination rates stagnating. The private sector could play a key role in finally bringing COVID-19 under control.

7 April 2022

How innovative financing will help prepare for future pandemics

COVAX, using an innovative finance model, has delivered over 1.2 billion doses to lower-income countries. Innovative financing models could equip governments worldwide to prepare for and mitigate future pandemics. Effective and sustainable…

7 April 2022

Avoiding COVID Complacency

While wealthy countries ease COVID-19 restrictions and welcome a return to normal life, many low-income countries are still struggling to get vaccines into people’s arms. The longer they remain short of the 70% immunization target, the more…

28 March 2022

Ending the COVID-19 pandemic means helping countries to catch-up with vaccination, not giving up

Like COVID-19, complacency can be contagious. Dr Seth Berkley argues that during a pandemic complacency can be very dangerous.

3 February 2022

The Equity Agenda in Fourth Industrial Revolution Healthcare Technology

The COVID-19 pandemic has demonstrated the power of innovative Fourth Industrial Revolution (4IR) technologies in healthcare systems. Unless these technologies are designed with equity at their core, we risk leaving some people even further…

21 January 2022

We can stop the cycle of new variants continuing indefinitely with a pandemic vaccine pool

Without it we could face further delays in the global rollout and risk the gulf between the vaccine haves and have nots widening.

21 December 2021

Dr Seth Berkley's reflections on 2021 and the global imperative for 2022

2021 has been another challenging pandemic year, but despite the challenges it saw important milestones, extraordinary resilience in Gavi-supported countries and progress on a number of fronts. In his annual end of year letter, Gavi CEO Dr Seth…

9 December 2021

We've had COVID-19 vaccines for one year. How can we make better use of them?

It has been one year since COVID-19 vaccines first became available in the UK. COVID-19 vaccines work well, but the question now is how can we make the best use of them? Getting first doses out to people in all countries has to become the…

7 December 2021

As the world’s first ever malaria vaccine is approved, we cannot let it be the last

Rather than marking the end of a very long journey we need to view the vaccine's arrival as the beginning of an important new one.

4 November 2021

Five crucial years, one unprecedented new pandemic and 324 million children immunised

Even with the adversities and challenges of the COVID-19 pandemic through 2020, Gavi maintained unyielding focus on leaving no one behind.

1 November 2021

Without global vaccination, all COVID immunity is at risk

A year from now, instead of potentially entering the pandemic endgame, we could find ourselves at the start of a new and perpetual cycle of revaccination or boosters for people who have already previously been protected.

1 November 2021

The Test of Pandemic Preparedness

The COVID-19 pandemic is the product of a globalized, interconnected world. Without new mechanisms that offer truly global approaches to crisis management and prevention, the experience of the past 18 months is likely to be repeated, with…

29 October 2021

Health is a political choice

COVAX can make even more of a difference if governments stop hoarding vaccine doses and allow the free flow of these crucial supplies.

29 October 2021

No one is safe until everyone is safe

To end the pandemic, the virus needs to be stamped out simultaneously across the world, but government hoarding and export restrictions are getting in the way of making this happen.

21 October 2021

“A moment of immense pride and joy”: Anuradha Gupta’s eight reflections on India’s billionth COVID-19 vaccine dose

As India celebrated its one-billionth COVID-19 vaccination, #VaccinesWork caught up with Anuradha Gupta, Gavi’s Deputy CEO and an Indian public health veteran.

30 September 2021

Routine immunisation worldwide holds firm despite the pandemic

Despite the havoc wrought by the COVID-19 pandemic on health systems worldwide, governments’ work to bring immunisation programmes back on track is paying off.

20 August 2021

How to eliminate cervical cancer - an expert explains

COVID-19 has caused a decline in the delivery of human papillomavirus (HPV) vaccines that protect girls from cervical cancer. Anuradha Gupta, the Deputy CEO of Gavi, explains what we must do to create more access to these vaccines.

9 August 2021

If we’re not careful, booster vaccines could end up giving the coronavirus a boost

The sooner we start using booster jabs, the more likely it is that we will need them.

3 August 2021

Intellectual Property and COVID-19 vaccines

During a pandemic supply bottlenecks of essential medical products are almost inevitable, but with COVID-19 this has been further exacerbated by governments hoarding doses and imposing export bans.

8 July 2021

Opinion: Reach 'zero-dose' children to build back better

We must seize this opportunity to shape our COVID-19 response as a chance to achieve better equity and social justice. What better way to do that than to focus on zero-dose children?

30 June 2021

How to Prevent the Next Pandemic

We need to make the development and distribution of vaccines a truly global endeavor.

11 June 2021

Countries must share COVID-19 vaccine doses; the sooner the better

Some of the world’s wealthiest countries nations have already committed to share doses with lower-income countries through COVAX: as G7 leaders meet this week, other governments must follow suit and share their doses now, because we only have a…

17 May 2021

The World Isn’t Getting Vaccinated Fast Enough. Here Are 4 Ways to Fix That

In an unprecedented show of global solidarity, the world came together to back COVAX, a unique global solution aimed at making equitable access to COVID-19 vaccines possible.

29 April 2021

Turning a short-term crisis into long-term change

Often, crisis responses and emergency funding do not lead to significant structural changes because their goal is to provide immediate relief, not drive long-term shifts. Immediate crisis relief and long-term structural changes, however, can…

25 March 2021

The growing threat of pandemics

Whilst COVID-19 caught the world off guard, the speed at which it spread and the extent of its impact on people’s lives came as a great shock to most. However, some were not surprised at all.

22 March 2021

COVID shows infectious disease is our greatest threat to global security

Unlike traditional security threats, infectious disease can’t be solved through sanctions, military posturing, deterrence or bilateral diplomacy, but rather through scientific collaboration, long-term investments in global health and resilient…

9 March 2021

Breaking the glass vial: Women at the forefront of COVID-19 vaccine

Leaders in global health have been working on COVAX – a global initiative to ensure the fair distribution of COVID-19 vaccines. Some of the top jobs are held by a diverse group of women, so in honour of International Women's Day we'd like to…

8 March 2021

International Women’s Day: Anuradha Gupta on ‘choose to challenge’

This International Women’s Day Vaccines Work is hosting a series of interviews with inspirational women from across the world. Here Anuradha Gupta, Gavi’s Deputy CEO, explains what ‘choose to challenge’ – this year’s IWD theme – means to her.

9 February 2021

Protecting Lower-Income Countries with COVID-19 Vaccines Requires Global Solidarity

The medical and moral imperative for equitable access to COVID-19 vaccines is why COVAX was created. Co-led by Gavi, the Vaccine Alliance, together with the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (…

5 January 2021

Globalizing the COVID Vaccine

In less than a year, the world has come together to develop effective COVID-19 vaccines and a multilateral platform for allocating them most efficiently around the world. But with the risk of vaccine nationalism still looming large, now is the…

12 November 2020

Until a coronavirus vaccine is ready, pneumonia vaccines may reduce deaths from COVID-19

The yearly influenza season threatens to make the COVID-19 pandemic doubly deadly, but I believe that this isn’t inevitable.

10 November 2020

Science can give us the tools to end the pandemic, but it needs funding

Vaccines, tests and treatments, alongside well-equipped health systems, are the solutions to bringing the Covid-19 pandemic under control. But this won’t happen without urgent investment, explains Jeremy Farrar. 

5 November 2020

How deliberately infecting volunteers with COVID-19 could help accelerate vaccine development

Josh Morrison, Co-founder and Executive Director of 1Day Sooner, an organisation that advocates on behalf of challenge trial volunteers, explains why.

27 October 2020

Why protecting, promoting essential services for women and children is now more critical than ever

Now, COVID-19 is unleashing substantial health, social and economic impacts in every corner of the globe. But it is the poorest countries and the most vulnerable communities around the world that stand to suffer the most from this protracted…

23 October 2020

Immunization Is the Best Weapon Against Poverty

Anti-vaxxers’ irresponsible misinformation ignores those with the most to lose by not vaccinating: the poorest and most vulnerable, who risk dying or sliding into medical impoverishment if they or their loved ones get sick. For much of the world’…

22 October 2020

We need a global response to the COVID-19 pandemic

President of Niger H.E. Issoufou Mahamadou talks about the importance of routine immunisation and Gavi support in Niger, and the need for ensuring universal access to COVID-19 vaccines through the COVAX Facility.

12 October 2020

A Moment of Truth in the Pandemic

As the most ambitious pandemic-response initiative ever conceived, the COVID-19 Vaccine Global Access Facility is the best chance the world has to bring the pandemic to an end. But to succeed, COVAX requires broad international buy-in, based on…

24 September 2020

Gavi’s commitment to diversity, equity and inclusion

We commit to fostering a just, equitable and diverse culture free from racism and discrimination in which all staff, partners and stakeholders feel empowered, safe and heard.

18 September 2020

The three Vs needed to end this pandemic

While scientific and vaccine manufacturing community make huge strides in the race towards that goal, it is important to remember that vaccines are only one of three Vs needed to beat this coronavirus.

26 June 2020

What is the COVAX pillar, why do we need it and how will it work?

With more than 200 COVID-19 vaccines already in development, why do we need the Access to COVID-19 Tools Accelerator Vaccine Pillar, or COVAX Pillar?

Last updated: 5 Oct 2022

Subscribe to our newsletter